It’s no secret that opioids are abused and SSRI are overused. Can cannabis come to the rescue? Delve into the science and practical application of cannabis in stress, anxiety and post-traumatic stress disorder (PTSD), potentially reducing reliance on pharmaceuticals and eliminating unwanted side effects.
While cannabis is a plant with diverse phytochemicals that work synergistically, solvent extracts of cannabis or preparations made from these extracts high in active cannabinoids are also available. These preparations can be more similar to concentrated, single-entity pharmaceutical drugs. Explore how the two most studied cannabinoids – THC and CBD – are metabolized by and affect the body via different routes of administration.
Faculty:
Kate Welch, PharmD
Founder, Delta Nine Solutions
An endocannabinoid deficiency may characterize the origin of numerous pain syndromes plus other health-related symptoms. The hypothesis: all humans have an underlying endocannabinoid tone, which produces negative effects if deficient. Learn about the scientific research and clinical data behind this theory plus how to upregulate the endocannabinoid system.
Faculty:
Ethan Russo, MD
Medical Director, Phytecs
An advanced look at the endocannabinoid system, or ECS, covering the unique retrograde signaling in the brain, the known polymorphisms, the pharmokinetics, the gender differences + the modulators of the ECS. Building on the foundational ECS module in Track I, take a deep dive into the intricacies + nuances of this complex system.
Faculty:
Lex Pelger
Scientist, Educator + Host, Psymposia
Opioid addiction is at crisis level in the US and around the world. Progressive practitioners and patients alike are lobbying for cannabis is as first-line therapy for opioid, alcohol, and other substance rehabilitation. Understand the conditions and situations where cannabis is and is not appropriate as an exit tool.
Faculty:
Mary Lynn Mathre, RN, MSN, CARN